Publications

Export 31 results:
Sort by: Author [ Title (Desc)] Type Year
Filters: First Letter Of Title is V  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U [V] W X Y Z   [Show ALL]
V
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366(15):1404-13. Abstract
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366(15):1404-13. Abstract
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366(15):1404-13. Abstract
Pakhotin P, Harmar AJ, Verkhratsky A, Piggins H. VIP receptors control excitability of suprachiasmatic nuclei neurones. Pflügers Archiv : European journal of physiology. 2006;452:7-15. Abstract
Sommerfield AJ, Wilkinson IB, Webb DJ, Frier BM. Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab. 2007;293(5):E1274-9. Abstract
Lavasani M, Gehrmann S, Gharaibeh B, Clark KA, Kaufmann RA, Péault B, et al. Venous graft-derived cells participate in peripheral nerve regeneration. PLoS ONE. 2011;6(9):e24801. Abstract
Findley CM, Cudmore MJ, Ahmed A, Kontos CD. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol. 2007;27(12):2619-26. Abstract
Cruden NL, Lang NN, Macgillivray TJ, Uren NG, Fox KA, Newby DE. Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb. Heart and vessels. 2011. Abstract
Love MP, Haynes WG, Gray GA, Webb DJ, McMurray JJ. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation. 1996;94(9):2131-7. Abstract
Love MP, Haynes WG, Gray GA, Webb DJ, McMurray JJ. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation. 1996;94(9):2131-7. Abstract
Aton SJ, Colwell CS, Harmar AJ, Waschek J, Herzog ED. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nature neuroscience. 2005;8:476-83. Abstract
Tavian M, Zheng B, Oberlin E, Crisan M, Sun B, Huard J, et al. The vascular wall as a source of stem cells. Ann N Y Acad Sci. 2005;1044:41-50. Abstract
Lang NN, Guðmundsdóttir IJ, Newby DE. Vascular PAR-1: Activity and Antagonism. Cardiovasc Ther. 2010. Abstract
Roberts JR, Perkins GD, Fujisawa T, Pettigrew KA, Gao F, Ahmed A, et al. Vascular endothelial growth factor promotes physical wound repair and is anti-apoptotic in primary distal lung epithelial and A549 cells. Crit Care Med. 2007;35(9):2164-70. Abstract
Lang NN, Myles RC, Burton FL, Hall DP, Chin YZ, Boon NA, et al. The vascular effects of rotigaptide in vivo in man. Biochem Pharmacol. 2008;76(10):1194-200. Abstract
Japp AG, Cruden NL, Amer DA, Li VK, Goudie EB, Johnston NR, et al. Vascular effects of apelin in vivo in man. Journal of the American College of Cardiology. 2008;52:908-13. Abstract
Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008;24(5):353-63. Abstract
Véniant M, Ménard J, Bruneval P, Morley S, Gonzales MF, Mullins J. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. The Journal of clinical investigation. 1996;98:1966-70. Abstract
Erridge C, Burdess A, Jackson AJ, Murray C, Riggio M, Lappin D, et al. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma. European journal of clinical investigation. 2008;38:713-20. Abstract
Lang NN, Cruden NL, Tse GH, Bloomfield P, Ludlam CA, Fox KA, et al. Vascular B1 kinin receptors in patients with congestive heart failure. J Cardiovasc Pharmacol. 2008;52(5):438-44. Abstract
Morley SD, Viard I, Chung BC, Ikeda Y, Parker KL, Mullins JJ. Variegated expression of a mouse steroid 21-hydroxylase/beta- galactosidase transgene suggests centripetal migration of adrenocortical cells. Molecular endocrinology (Baltimore, Md.). 1996;10:585-98. Abstract
Lange A, Moran CM, Palka P, Fenn LN, Sutherland GR, McDicken WN. The variation of integrated backscatter in human hearts in differing ultrasonic transthoracic views. J Am Soc Echocardiogr. 1995;8(6):830-8. Abstract
Freathy RM, Mook-Kanamori DO, Sovio U, Prokopenko I, Timpson NJ, Berry DJ, et al. Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nat Genet. 2010;42(5):430-5. Abstract
Buysschaert I, Carruthers KF, Dunbar DR, Peuteman G, Rietzschel E, Belmans A, et al. A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study. European heart journal. 2010;31:1132-41. Abstract
Connor M, Williams A, Macleod M, Smith C. Vanishing diplopia: a problem case. Practical neurology. 2007;7:268-71.